5.2.1, 5-2.2.1, 8.1, 8.1.1: response limited 8 characters and field size of 65, references to "no upper limit" removed
5-3.12: typo fixed
Section 11: added Privacy to section title and added references to privacy in question text.
15-1.10: added "IV" to "Prepare blinded capsules/IV (placebo and/or FDA approved drug)" selection
16.2.22: duplicate question text removed
Section 40: typo in section heading fixed
43.6: link to MADRC pdf updated
C2.1: added "(M-Inform)" to Medical COI option
Text of correspondence will now display in email notification
For IRBMED studies, the review type has been added to the IRB outcome notice
Fixed typo in Renewal Deadline reminder notice
Additional email recipients added to CTO email notifications
Sort order on the All Studies tab is now by ID instead of study name
For studies with multiple risk levels, study teams will no longer have to re-enter the arm names when submitting an application, continuing review, or amendment
Support links for step-by-step procedures and contact information have been added to the study team home workspace
Documents tab reformatted: two sections 1) Approved Documents (Finalized Documents, Documents in the Study, and Associated Proposals (PAFs) and 2) Supporting Documents (Shared Supporting Documents, Internal Supporting Documents, Historical Documents)
On the Approval Period page, added "as applicable" to the certification statement
Updated Section 5 checklist item to "Are the research procedures consistent with sound research design, and is it a reasonable expectation that the research design could yield the expected results?"
PRC & MCRU
MCRU title changed from "Chair" to "Director"
Additional fields will trigger an Engage posting